EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 366 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $262,284 | -11.1% | 13,725 | -27.1% | 0.01% | -33.3% |
| Q3 2022 | $295,000 | -46.8% | 18,828 | -29.4% | 0.01% | -45.5% |
| Q2 2022 | $555,000 | +107.1% | 26,683 | +125.3% | 0.02% | +144.4% |
| Q1 2022 | $268,000 | +24.1% | 11,842 | -0.1% | 0.01% | 0.0% |
| Q4 2021 | $216,000 | -97.8% | 11,856 | -98.2% | 0.01% | -97.8% |
| Q4 2016 | $9,888,000 | -3.5% | 663,180 | -17.2% | 0.40% | +22.4% |
| Q3 2016 | $10,245,000 | +1503.3% | 800,980 | +371.2% | 0.33% | +842.9% |
| Q2 2015 | $639,000 | – | 170,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |